Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis

Movement Disorders

Volumn 18, Issue 3, 2003, Pages 342-345

  Kim, Joong Seok ^a   Lee, Kwang Soo ^a   Han, Si Ryung ^a   Chung, Yong An ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Extrapontine myelinolysis; IPTSPECT; Parkinsonism

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARBIDOPA PLUS LEVODOPA; CISPLATIN; DOPAMINE TRANSPORTER; IODINE 123; SODIUM; SODIUM CHLORIDE;

ADULT; ARTICLE; ATAXIA; BRADYKINESIA; BRAIN INJURY; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; COMORBIDITY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DYSARTHRIA; FEMALE; GAIT DISORDER; GASTRECTOMY; HUMAN; HYPONATREMIA; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOSIS; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH CARCINOMA; STRIATONIGRAL DEGENERATION; TREMOR;

ANTIPARKINSON AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; HYPONATREMIA; ISOTONIC SOLUTIONS; LEVODOPA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE; NERVE TISSUE PROTEINS; PARKINSONIAN DISORDERS; PROTEIN BINDING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; TROPANES;

EID: 0037356172     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10331     Document Type: Article

References (19)

1. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol Psychiatry 1959;81:154-172.
2. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979;102:361-385.
3. Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 1987;6:262-270.
4. Brunner JE, Redmond JM, Hagger AM, Kruger DF, Elias SB. Central Pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 1990;27:61-66.
5. Stam J, van Oers MH, Verbeeten B Jr. Recovery after central pontine myelinolysis. J Neurol 1984;231:52-53.
6. Dickoff DJ, Raps M, Yahr MD. Striatal syndrome following hyponatremia and its rapid correction. Arch Neurol 1988;45:112-114.
7. Tinker R, Anderson MG, Anand P, Kermode A, Harding AE. Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatremia. J Neurol Neurosurg Psychiatry 1990;53:87-88.
8. Maraganore DM, Folger WN, Swanson JW, Ahlskog JE. Movement disorders as sequelae of central pontine myelinolysis: report of three cases. Mov Disord 1992;7:142-148.
9. Tomita I, Satoh H, Satoh A, Seto M, Tsujihata M, Yoshimura T. Extrapontine myelinolysis presenting with parkinsonism as a sequel of rapid correction of hyponatremia. J Neurol Neurosurg Psychiatry 1997;62:422-423.
10. Sullivan AA, Chervin RD, Albin RL. Parkinsonism after correction of hyponatremia with radiological central pontine myelinolysis and changes in the basal ganglia. J Clin Neurosci 2000;7:256-259.
11. Yau TK, Yiu HY, Lee WM. Central Pontine myelinolysis: report of two occurrences after cisplatin-containing chemotherapy for nasopharyngeal carcinoma. Clin Oncol 1993;5:395-396.
12. DeAngelis LM, Delattre JY, Posner JB. Neurological complications of chemotherapy and radiation therapy. In: Aminoff MJ, editor. Neurology and general medicine. 3rd ed. Philadelphia: Churchill Livingstone; 2001. p 437-458.
13. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med 1993;329:1790-1796.
14. Hutchinson FN, Perez EA, Gandara DR, Lawrence HJ, Kaysen GA. Renal salt wasting in patients treated with cisplatin. Ann Intern Med 1988;108:21-25.
15. Nagamitsu S, Matsuishi T, Yamashita Y, Yamada S, Kato H. Extrapontine myelinolysis with parkinsonism after rapid correction of hyponatremia: high cerebral fluid level of homovanillic acid and successful dopaminergic treatment. J Neural Transm 1999;106:949-953.
16. Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB. Iodine-123-β-CIT and Iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med 1998;39:1500-1508.
17. Schwarz J, Linke R, Kerner M, Mozley PD, Trenkwalder C, Gasser T, Tatsch K. Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis. Arch Neurol 2000;57:205-208.
18. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 1996;16:436-447.
19. Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol 2000;13:691-697.